These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

850 related items for PubMed ID: 12425560

  • 1. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E, Botta F, Testa E, Romagnoli P, Polegato S, Malfatti F, Fumagalli A, Chiarbonello B, Risso D, Testa R.
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [Abstract] [Full Text] [Related]

  • 2. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [Abstract] [Full Text] [Related]

  • 3. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection.
    Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T.
    Am J Gastroenterol; 2001 Nov; 96(11):3142-6. PubMed ID: 11721762
    [Abstract] [Full Text] [Related]

  • 4. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX, Yan LN, Wang WT, Xu MQ, Yang JY.
    Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
    [Abstract] [Full Text] [Related]

  • 5. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.
    Mishra P, Desai N, Alexander J, Singh DP, Sawant P.
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1232-5. PubMed ID: 17688663
    [Abstract] [Full Text] [Related]

  • 6. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [Abstract] [Full Text] [Related]

  • 7. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
    Sun QF, Ding JG, Xu DZ, Chen YP, Hong L, Ye ZY, Zheng MH, Fu RQ, Wu JG, Du QW, Chen W, Wang XF, Sheng JF.
    J Viral Hepat; 2009 Jul; 16(7):464-70. PubMed ID: 19413694
    [Abstract] [Full Text] [Related]

  • 8. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R.
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [Abstract] [Full Text] [Related]

  • 9. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
    Dai CY, Chuang WL, Hou NJ, Lee LP, Hsieh MY, Lin ZY, Chen SC, Huang JF, Hsieh MY, Wang LY, Tsai JF, Wen-Yu, Yu ML.
    Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
    [Abstract] [Full Text] [Related]

  • 10. [Analysis of short-term prognosis on patients with chronic severe hepatitis B using the model for end-stage liver disease].
    Zhou J, He WF, Tang XE.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):416-8. PubMed ID: 17631710
    [Abstract] [Full Text] [Related]

  • 11. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
    Bae WK, Lee JS, Kim NH, Kim KA, Moon YS, Oh MK.
    Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
    [Abstract] [Full Text] [Related]

  • 12. [Clinical usefulness of DeltaMELD to predict the survival of patients with liver cirrhosis].
    Eun SH, Kim YS, Jang JY, Cheon YG, Kim YS, Cho YD, Lee JS, Lee MS, Kim JH, Shim CS, Kim BS.
    Korean J Hepatol; 2006 Dec; 12(4):530-8. PubMed ID: 17237631
    [Abstract] [Full Text] [Related]

  • 13. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
    Cai CJ, Chen HA, Lu MQ, Chen GH.
    Chin Med J (Engl); 2008 Oct 20; 121(20):2065-9. PubMed ID: 19080277
    [Abstract] [Full Text] [Related]

  • 14. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.
    Nyblom H, Björnsson E, Simrén M, Aldenborg F, Almer S, Olsson R.
    Liver Int; 2006 Sep 20; 26(7):840-5. PubMed ID: 16911467
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    J Hepatol; 2005 Jun 20; 42(6):826-32. PubMed ID: 15885353
    [Abstract] [Full Text] [Related]

  • 16. The model for end-stage liver disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice.
    Antaki F, Lukowski A.
    J Clin Gastroenterol; 2007 Apr 20; 41(4):412-5. PubMed ID: 17413612
    [Abstract] [Full Text] [Related]

  • 17. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep 20; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B.
    Chan HL, Chim AM, Lau JT, Hui AY, Wong VW, Sung JJ.
    Am J Gastroenterol; 2006 Jul 20; 101(7):1516-23. PubMed ID: 16863555
    [Abstract] [Full Text] [Related]

  • 19. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
    Schepke M, Roth F, Fimmers R, Brensing KA, Sudhop T, Schild HH, Sauerbruch T.
    Am J Gastroenterol; 2003 May 20; 98(5):1167-74. PubMed ID: 12809844
    [Abstract] [Full Text] [Related]

  • 20. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
    Sheth SG, Flamm SL, Gordon FD, Chopra S.
    Am J Gastroenterol; 1998 Jan 20; 93(1):44-8. PubMed ID: 9448172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.